Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study

Publisher： Karger

E-ISSN： 1421-9794|58|5|371-380

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.5, 2012-12, pp. : 371-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer

By  

Chemotherapy, Vol. 52, Iss. 2, 2006-04 ,pp. : 98-102

Karger

Access to resources Recommend Favorite

Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

By  

Chemotherapy, Vol. 50, Iss. 6, 2004-12 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study

By  

Chemotherapy, Vol. 54, Iss. 1, 2007-12 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-12 ,pp. : 232-238

Karger

Access to resources Recommend Favorite